Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Recruiting now · Not applicable

Conditions studied: Ischemic Stroke, Transient Ischemic Attack (TIA)

In brief

The purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value. Participants will receive usual care after discharge (control group) or be managed with a WeChat-based intelligent management system after discharge (intervention group). At one year, all patients will undergo face-to-face follow-up to assess clinical events, medication adherence, and the achievement of target risk factor levels.

Key facts

Study ID
NCT06783049
Run by
Beijing Tiantan Hospital
People needed
4490
Starts
2025-03-03
Expected to finish
2027-01-31
Last updated by the study team
2026-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.